HERCEPTIN Side Effects

7020464-7 | Breast Cancer Metastatic
on Sep 24, 2010 Female patient from UNITED STATES , weighting 142.6 lb, was treated with Herceptin (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer metastatic. Herceptin dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ).

7005464-5 | Aortic Thrombosis, Arrhythmia, Mitral Valve Incompetence, Orthostatic Hypotension, Phlebitis, Pulmonary Embolism
Patient was taking Herceptin (View Usage). Patient had the following side effects: aortic thrombosis, arrhythmia (What is arrhythmia?), mitral valve incompetence, orthostatic hypotension, phlebitis, pulmonary embolism (What is pulmonary embolism?) on Sep 09, 2010 from FRANCE Additional patient health information: Female patient , 79 years of age, was diagnosed with breast cancer metastatic and. Herceptin dosage: . During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), EXEMESTANE (View Exemestane Review and Exemestane Label ), TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ).

6988223-9 | Completed Suicide
Adverse event was reported on Sep 10, 2010 by a Female patient taking Herceptin (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 60 years of age, After Herceptin was administered, patient had the following side effects: completed suicide.

6988180-5 | Ejection Fraction Decreased, Fatigue, Palmar-plantar Erythrodysaesthesia Syndrome
on Sep 07, 2010 Female patient from VENEZUELA , weighting 187.4 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Herceptin (View Usage). Patient experienced the following unwanted or unexpected effects: ejection fraction decreased, fatigue, palmar-plantar erythrodysaesthesia syndrome. Herceptin dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ).


6973214-4 | Live Birth, Transient Tachypnoea Of The Newborn
on Sep 01, 2010 Male patient from UNITED KINGDOM , weighting 7.05 lb, was diagnosed with ejection fraction decreased and was treated with Herceptin (View Usage). Patient had the following side effects: live birth, transient tachypnoea of the newborn. Herceptin dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ).

6968508-2 | Reversible Posterior Leukoencephalopathy Syndrome
Patient was taking Herceptin (View Usage). After Herceptin was administered, patient had the following side effects: reversible posterior leukoencephalopathy syndrome on Sep 01, 2010 from CANADA Additional patient health information: Female patient , 55 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Herceptin dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ). Patient was hospitalized.

6968401-5 | Interstitial Lung Disease
Adverse event was reported on Aug 27, 2010 by a Female patient taking Herceptin (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 63 years of age, Patient experienced the following unwanted or unexpected effects: interstitial lung disease. During the same period patient was treated with TAXOTERE (Dose Is Uncertain) (View Taxotere Review and Taxotere Label ), ENDOXAN (Doseage Is Uncertain, Form Uncertainly.) (View Endoxan Review and Endoxan Label ).

6968342-3 | Acute Pulmonary Oedema, Atrial Fibrillation, Blood Pressure Immeasurable, Cardiac Failure Acute, Chest Discomfort, Coronary Artery Stenosis, Dyspnoea, Wheezing
on Aug 27, 2010 Female patient from JAPAN , weighting 105.8 lb, was diagnosed with breast cancer metastatic and was treated with Herceptin (View Usage). Patient had the following side effects: acute pulmonary oedema, atrial fibrillation (What is atrial fibrillation?), blood pressure immeasurable, cardiac failure acute, chest discomfort, coronary artery stenosis, dyspnoea, wheezing. Herceptin dosage: . During the same period patient was treated with XELODA (3 Weeks Administration Followed By 1 Week Rest.) (View Xeloda Review and Xeloda Label ), TYKERB (View Tykerb Review and Tykerb Label ), NAVELBINE (2 Weeks Administration Followed By 1 Week Rest.) (View Navelbine Review and Navelbine Label ), CALONAL (Form:uncertainty) (View Calonal Review and Calonal Label ). Patient was hospitalized.

6968266-1 | Pregnancy, Transient Tachypnoea Of The Newborn
on Sep 01, 2010 Male patient from UNITED KINGDOM , weighting 7.05 lb, was diagnosed with ejection fraction decreased and was treated with Herceptin (View Usage). After Herceptin was administered, patient had the following side effects: pregnancy (What is pregnancy?), transient tachypnoea of the newborn. Herceptin dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ).

6968248-X | Leukaemia
Patient was taking Herceptin (View Usage). Patient experienced the following unwanted or unexpected effects: leukaemia on Sep 02, 2010 from GREECE Additional patient health information: Female patient , 48 years of age, . Herceptin dosage: .

6965810-5 | Myocardial Infarction
Adverse event was reported on Aug 27, 2010 by a Female patient taking Herceptin (View Usage) (Dosage: Had Received 7 Cycles) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED KINGDOM , 58 years of age, Patient had the following side effects: myocardial infarction.

6965576-9 | Cardiac Failure, Pulmonary Oedema
on Aug 25, 2010 Female patient from JAPAN , weighting 101.4 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Herceptin (View Usage). After Herceptin was administered, patient had the following side effects: cardiac failure, pulmonary oedema. Herceptin dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), ORADOL (Dose Form: Lozenge, Route: Oropharingeal) (View Oradol Review and Oradol Label ), DEXALTIN (View Dexaltin Review and Dexaltin Label ), PYDOXAL (View Pydoxal Review and Pydoxal Label ), FLAVITAN (View Flavitan Review and Flavitan Label ). Patient was hospitalized.

6960859-0 | Interstitial Lung Disease
on Apr 27, 2010 Female patient from JAPAN , 63 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Herceptin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Herceptin dosage: . During the same period patient was treated with TAXOTERE (Dose Is Uncertain) (View Taxotere Review and Taxotere Label ), ENDOXAN (Doseage Is Uncertain, Form Uncertainly.) (View Endoxan Review and Endoxan Label ).

6960842-5 | Neurotoxicity
Patient was taking Herceptin (View Usage). Patient had the following side effects: neurotoxicity on Aug 24, 2010 from AUSTRIA Additional patient health information: Female patient , weighting 119.0 lb, . Herceptin dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ).

6960730-4 | Bradycardia, Cardiac Arrest, Chest Pain
Adverse event was reported on Aug 24, 2010 by a Female patient taking Herceptin (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: AUSTRALIA , weighting 134.5 lb, After Herceptin was administered, patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?), chest pain (What is chest pain?). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.

6958584-5 | Neutropenic Colitis
on Aug 25, 2010 Female patient from UNITED STATES , 40 years of age, was treated with Herceptin (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenic colitis. Herceptin dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6958531-6 | Renal Failure Chronic
on Aug 23, 2010 Female patient from PORTUGAL , weighting 138.9 lb, was diagnosed with breast cancer (What is breast cancer?), hypertension, anxiety (What is anxiety?) and was treated with Herceptin (View Usage). Patient had the following side effects: renal failure chronic. Herceptin dosage: Initial Dose (loading Dose).. During the same period patient was treated with AMLODIPINE BESYLATE (Dose: 1 Unitary, Frequency: Daily) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ENALAPRIL MALEATE (Dose: 1 Unitary, Frequency: Daily) (View Enalapril Maleate Review and Enalapril Maleate Label ), HYDROCHLOROTHIAZIDE (Dose: 1 Unitary, Frequency: Daily) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZOLPIDEM TARTRATE (Dose: 1 Unitary, Frequency: Daily) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), ALPRAZOLAM (Dose: 1 Unitary, Frequency: Daily) (View Alprazolam Review and Alprazolam Label ), ALLOPURINOL (Dose: 1 Unitary, Frequency: Daily) (View Allopurinol Review and Allopurinol Label ), ETODOLAC (Frequency: Daily) (View Etodolac Review and Etodolac Label ).

6955850-4 | Aortic Thrombosis, Arrhythmia, Malignant Neoplasm Progression, Mitral Valve Incompetence, Orthostatic Hypotension, Phlebitis, Pulmonary Embolism
Patient was taking Herceptin (View Usage). After Herceptin was administered, patient had the following side effects: aortic thrombosis, arrhythmia (What is arrhythmia?), malignant neoplasm progression, mitral valve incompetence, orthostatic hypotension, phlebitis, pulmonary embolism (What is pulmonary embolism?) on Aug 20, 2010 from FRANCE Additional patient health information: Female patient , 79 years of age, . Herceptin dosage: . During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ).

6955723-7 | Atrioventricular Block Complete, Bundle Branch Block Left, Bundle Branch Block Right, Cardiac Failure Congestive, Cardiomyopathy
Adverse event was reported on Aug 16, 2010 by a Female patient taking Herceptin (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , weighting 105.8 lb, Patient experienced the following unwanted or unexpected effects: atrioventricular block complete, bundle branch block left, bundle branch block right, cardiac failure congestive, cardiomyopathy (What is cardiomyopathy?). Patient was hospitalized.

6945439-5 | Palmar-plantar Erythrodysaesthesia Syndrome
on Aug 18, 2010 Female patient from VENEZUELA , weighting 160.9 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Herceptin (View Usage). Patient had the following side effects: palmar-plantar erythrodysaesthesia syndrome. Herceptin dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ).

6945338-9 | Autoimmune Thyroiditis, Thyrotoxic Crisis
on Aug 24, 2010 Female patient from GERMANY , weighting 155.4 lb, was diagnosed with hypertension and was treated with Herceptin (View Usage). After Herceptin was administered, patient had the following side effects: autoimmune thyroiditis, thyrotoxic crisis. Herceptin dosage: Tch Scheme, Loading Dose On First Day 290 Mg. During the same period patient was treated with DOCETAXEL (Tch Scheme) (View Docetaxel Review and Docetaxel Label ), CARBOPLATIN (Tch Scheme) (View Carboplatin Review and Carboplatin Label ), FEMARA (View Femara Review and Femara Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6942869-2 | Cardiac Tamponade, Infusion Related Reaction, Leukocytosis, Lung Neoplasm, Malignant Neoplasm Progression, Pericardial Effusion, Pleural Effusion
Patient was taking Herceptin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac tamponade, infusion related reaction, leukocytosis, lung neoplasm, malignant neoplasm progression, pericardial effusion, pleural effusion on Aug 17, 2010 from BRAZIL Additional patient health information: Female patient , weighting 145.1 lb, was diagnosed with breast cancer (What is breast cancer?) and. Herceptin dosage: . During the same period patient was treated with ZOLEDRONATE (View Zoledronate Review and Zoledronate Label ), DECADRON (View Decadron Review and Decadron Label ), KYTRIL (View Kytril Review and Kytril Label ), LETROZOLE (View Letrozole Review and Letrozole Label ). Patient was hospitalized.

6942838-2 | Organising Pneumonia
Adverse event was reported on Aug 16, 2010 by a Female patient taking Herceptin (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: SPAIN , 60 years of age, Patient had the following side effects: organising pneumonia.

6942782-0 | Interstitial Lung Disease, Lymphangiosis Carcinomatosa
on Aug 19, 2010 Female patient from JAPAN , weighting 134.5 lb, was diagnosed with breast cancer metastatic and was treated with Herceptin (View Usage). After Herceptin was administered, patient had the following side effects: interstitial lung disease, lymphangiosis carcinomatosa. Herceptin dosage: . During the same period patient was treated with MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), ARTIST (Note: Divided Into 2 Doses.) (View Artist Review and Artist Label ), BEZATOL SR (View Bezatol Sr Review and Bezatol Sr Label ), ADALAT (View Adalat Review and Adalat Label ), DIOVAN (View Diovan Review and Diovan Label ). Patient was hospitalized.

6940693-8 | Pericardial Effusion
on Aug 18, 2010 Female patient from UNITED STATES , weighting 134.9 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Herceptin (View Usage). Patient experienced the following unwanted or unexpected effects: pericardial effusion. Herceptin dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), TAXOL (View Taxol Review and Taxol Label ).

6938789-X | Atrioventricular Block Complete, Bundle Branch Block Left, Bundle Branch Block Right, Cardiac Failure Congestive, Cardiomyopathy
Patient was taking Herceptin (View Usage). Patient had the following side effects: atrioventricular block complete, bundle branch block left, bundle branch block right, cardiac failure congestive, cardiomyopathy (What is cardiomyopathy?) on Aug 10, 2010 from JAPAN Additional patient health information: Female patient , weighting 105.8 lb, was diagnosed with breast cancer (What is breast cancer?) and. Herceptin dosage: . Patient was hospitalized.

6937682-6 | Acute Pulmonary Oedema, Cardiomegaly, Chills, Congestive Cardiomyopathy, Fatigue, Pneumonia, Tachycardia
Adverse event was reported on Aug 20, 2010 by a Female patient taking Herceptin (View Usage) (Dosage: 405 Mg) . Location: UNITED STATES , weighting 145.5 lb, After Herceptin was administered, patient had the following side effects: acute pulmonary oedema, cardiomegaly, chills, congestive cardiomyopathy, fatigue, pneumonia (What is pneumonia?), tachycardia. During the same period patient was treated with TAXOL (402 Mg) (View Taxol Review and Taxol Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ). Patient was hospitalized.

6936598-9 | Lymphadenopathy, Lymphadenopathy Mediastinal, Malaise, Neutropenia, Pyrexia, Skin Lesion
on Aug 10, 2010 Female patient from UNITED STATES , 78 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Herceptin (View Usage). Patient experienced the following unwanted or unexpected effects: lymphadenopathy, lymphadenopathy mediastinal, malaise, neutropenia, pyrexia, skin lesion. Herceptin dosage: . During the same period patient was treated with CYTOXAN (View Cytoxan Review and Cytoxan Label ), TAXOTERE (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

6936583-7 | Cardiac Failure, Cardiomyopathy, Ejection Fraction Decreased, Respiratory Failure
on Aug 13, 2010 Female patient from UNITED STATES , weighting 134.5 lb, was treated with Herceptin (View Usage). Patient had the following side effects: cardiac failure, cardiomyopathy (What is cardiomyopathy?), ejection fraction decreased, respiratory failure. Herceptin dosage: . During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ), AROMASIN (View Aromasin Review and Aromasin Label ), FASLODEX (View Faslodex Review and Faslodex Label ), TAXOTERE (View Taxotere Review and Taxotere Label ), NAVELBINE (View Navelbine Review and Navelbine Label ), ABRAXANE (View Abraxane Review and Abraxane Label ), FIORINAL (View Fiorinal Review and Fiorinal Label ).

6936569-2 | Metastases To Central Nervous System
Patient was taking Herceptin (View Usage). After Herceptin was administered, patient had the following side effects: metastases to central nervous system on Aug 12, 2010 from UNITED STATES Additional patient health information: Female patient , 33 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Herceptin dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ).

6936470-4 | Arrhythmia, Cardiac Failure Congestive, Dyspnoea, Lower Respiratory Tract Infection, Pleural Effusion
Adverse event was reported on Aug 13, 2010 by a Female patient taking Herceptin (View Usage) (Dosage: 600mg Loading Dose On The 8 August 2009, 450 Mg On The 31 August 2009.) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED KINGDOM , weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), cardiac failure congestive, dyspnoea, lower respiratory tract infection, pleural effusion. During the same period patient was treated with EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6928255-X | Acute Pulmonary Oedema, Atrial Fibrillation, Blood Pressure Immeasurable, Cardiac Failure Acute, Chest Discomfort, Coronary Artery Stenosis, Dyspnoea, Wheezing
on Aug 09, 2010 Female patient from JAPAN , weighting 105.8 lb, was diagnosed with breast cancer metastatic and was treated with Herceptin (View Usage). Patient had the following side effects: acute pulmonary oedema, atrial fibrillation (What is atrial fibrillation?), blood pressure immeasurable, cardiac failure acute, chest discomfort, coronary artery stenosis, dyspnoea, wheezing. Herceptin dosage: . During the same period patient was treated with XELODA (3 Weeks Administration Followed By 1 Week Rest.) (View Xeloda Review and Xeloda Label ), TYKERB (View Tykerb Review and Tykerb Label ), NAVELBINE (2 Weeks Administration Followed By 1 Week Rest.) (View Navelbine Review and Navelbine Label ), CALONAL (View Calonal Review and Calonal Label ). Patient was hospitalized.

6923157-7 | Bile Duct Obstruction, Breast Disorder, Palmar-plantar Erythrodysaesthesia Syndrome
on Aug 03, 2010 Female patient from JAPAN , weighting 110.2 lb, was diagnosed with breast cancer recurrent and was treated with Herceptin (View Usage). After Herceptin was administered, patient had the following side effects: bile duct obstruction, breast disorder, palmar-plantar erythrodysaesthesia syndrome. Herceptin dosage: . During the same period patient was treated with XELODA (2 Weeks Administration Followed By 1 Week Rest) (View Xeloda Review and Xeloda Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6921005-2 | Nephropathy Toxic
Patient was taking Herceptin (View Usage). Patient experienced the following unwanted or unexpected effects: nephropathy toxic on Aug 04, 2010 from DENMARK Additional patient health information: Female patient , 61 years of age, weighting 149.9 lb, was diagnosed with back pain (What is back pain?) and. Herceptin dosage: . During the same period patient was treated with LETROZOLE (Frequency: Daily) (View Letrozole Review and Letrozole Label ), IBUMETIN (View Ibumetin Review and Ibumetin Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ).

6919211-6 | Infusion Related Reaction, Leukocytosis, Lung Neoplasm, Malignant Neoplasm Progression
Adverse event was reported on Aug 03, 2010 by a Female patient taking Herceptin (View Usage) (Dosage: ) . Location: BRAZIL , 51 years of age, Patient had the following side effects: infusion related reaction, leukocytosis, lung neoplasm, malignant neoplasm progression. During the same period patient was treated with ZOLEDRONATE (View Zoledronate Review and Zoledronate Label ), DECADRON (View Decadron Review and Decadron Label ), KYTRIL (View Kytril Review and Kytril Label ).

6919158-5 | Pregnancy, Transient Tachypnoea Of The Newborn
on Jul 30, 2010 Male patient from UNITED KINGDOM , weighting 7.05 lb, was diagnosed with ejection fraction decreased and was treated with Herceptin (View Usage). After Herceptin was administered, patient had the following side effects: pregnancy (What is pregnancy?), transient tachypnoea of the newborn. Herceptin dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ).

6915243-2 | Asthenia, Cardiac Disorder, Cerebrovascular Accident, Fatigue, Gait Disturbance, Thrombosis
on Aug 06, 2010 Female patient from UNITED STATES , 59 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Herceptin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, cardiac disorder, cerebrovascular accident, fatigue, gait disturbance, thrombosis. Herceptin dosage: . Patient was hospitalized.

6910608-7 | Interstitial Lung Disease, Lymphangiosis Carcinomatosa
Patient was taking Herceptin (View Usage). Patient had the following side effects: interstitial lung disease, lymphangiosis carcinomatosa on Jul 30, 2010 from JAPAN Additional patient health information: Female patient , weighting 134.5 lb, was diagnosed with breast cancer metastatic and. Herceptin dosage: . During the same period patient was treated with MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), ARTIST (Note: Divided Into 2 Doses.) (View Artist Review and Artist Label ), BEZATOL SR (View Bezatol Sr Review and Bezatol Sr Label ), ADALAT (View Adalat Review and Adalat Label ), DIOVAN (View Diovan Review and Diovan Label ). Patient was hospitalized.

6905935-3 | Metastases To Central Nervous System
Adverse event was reported on Jul 28, 2010 by a Female patient taking Herceptin (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 33 years of age, After Herceptin was administered, patient had the following side effects: metastases to central nervous system. During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ).

6900228-2 | Hepatic Failure
on Jul 22, 2010 Female patient from UNITED STATES , weighting 198.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Herceptin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic failure. Herceptin dosage: Dose Reported As 376 Mg (4mg/kg). During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), TAXOL (View Taxol Review and Taxol Label ).

6895444-2 | Blood Creatinine Increased, Blood Urea Increased, Haematuria, Nephropathy Toxic, Pollakiuria, Proteinuria, Thirst, Weight Decreased
on Jul 23, 2010 Female patient from DENMARK , 61 years of age, was diagnosed with back pain (What is back pain?) and was treated with Herceptin (View Usage). Patient had the following side effects: blood creatinine increased, blood urea increased, haematuria, nephropathy toxic, pollakiuria, proteinuria, thirst, weight decreased. Herceptin dosage: . During the same period patient was treated with LETROZOLE (Frequency: Daily) (View Letrozole Review and Letrozole Label ), IBUMETIN (View Ibumetin Review and Ibumetin Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ).

6894946-2 | Asthenia, Malaise, Motor Neurone Disease, Peripheral Motor Neuropathy
Patient was taking Herceptin (View Usage). After Herceptin was administered, patient had the following side effects: asthenia, malaise, motor neurone disease, peripheral motor neuropathy on Jul 22, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 59 years of age, weighting 132.3 lb, was diagnosed with breast cancer (What is breast cancer?) and. Herceptin dosage: . During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LETROZOLE (View Letrozole Review and Letrozole Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ).

6894905-X | Hepatic Failure
Adverse event was reported on Jul 22, 2010 by a Female patient taking Herceptin (View Usage) (Dosage: Dose Reported As 376 Mg (4mg/kg)) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , weighting 198.0 lb, Patient experienced the following unwanted or unexpected effects: hepatic failure. During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), TAXOL (View Taxol Review and Taxol Label ).

6894877-8 | Breast Cancer, Cardiac Disorder, Cardiac Failure Congestive, Malignant Pleural Effusion
on Jul 26, 2010 Female patient from JAPAN , weighting 125.7 lb, was diagnosed with breast cancer metastatic and was treated with Herceptin (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?), cardiac disorder, cardiac failure congestive, malignant pleural effusion. Herceptin dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), TAXOTERE (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

6887765-4 | Agranulocytosis, Depression, Neutropenia, Suicide Attempt
on Jul 21, 2010 Female patient from SWITZERLAND , 64 years of age, was treated with Herceptin (View Usage). After Herceptin was administered, patient had the following side effects: agranulocytosis, depression (What is depression?), neutropenia, suicide attempt. Herceptin dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CLOPIN ECO (View Clopin Eco Review and Clopin Eco Label ), REMERON (View Remeron Review and Remeron Label ), IMOVANE (View Imovane Review and Imovane Label ).

6887745-9 | C-reactive Protein Increased, Leukopenia, Procalcitonin Increased, Pyrexia
Patient was taking Herceptin (View Usage). Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, leukopenia, procalcitonin increased, pyrexia on Jul 21, 2010 from POLAND Additional patient health information: Female patient , 53 years of age, . Herceptin dosage: . During the same period patient was treated with NAVELBINE (View Navelbine Review and Navelbine Label ). Patient was hospitalized.

6887680-6 | Bile Duct Obstruction, Hypoaesthesia, Mastitis, Neuropathy Peripheral, Palmar-plantar Erythrodysaesthesia Syndrome
Adverse event was reported on Jul 16, 2010 by a Female patient taking Herceptin (View Usage) (Dosage: ) was diagnosed with breast cancer recurrent and. Location: JAPAN , weighting 110.2 lb, Patient had the following side effects: bile duct obstruction, hypoaesthesia, mastitis, neuropathy peripheral, palmar-plantar erythrodysaesthesia syndrome. During the same period patient was treated with XELODA (2 Weeks Administration Followed By 1 Week Rest) (View Xeloda Review and Xeloda Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

6887667-3 | Acute Lymphocytic Leukaemia, Acute Myeloid Leukaemia
on Jul 22, 2010 Female patient from FRANCE , weighting 189.6 lb, was treated with Herceptin (View Usage). After Herceptin was administered, patient had the following side effects: acute lymphocytic leukaemia, acute myeloid leukaemia. Herceptin dosage: Form: Powder And Solvent For Solution For Infusion. Route: Intravenous (not Otherwise Specified).. During the same period patient was treated with FLUOROURACIL (Form: Solution For Infusion. Route: Intravenous (not Otherwise Specified).) (View Fluorouracil Review and Fluorouracil Label ), TAXOTERE (Form: Solution For Infusion. Route: Intravenous (not Otherwise Specified). Strength: 80 Mg/ml.) (View Taxotere Review and Taxotere Label ), CYCLOPHOSPHAMIDE (Form: Powder+solvent (lyophilisate). Route: Intravenous (not Otherwise Specified.) (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN HYDROCHLORIDE (View Epirubicin Hydrochloride Review and Epirubicin Hydrochloride Label ), CRESTOR (View Crestor Review and Crestor Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ). Patient was hospitalized.

6883061-X | Cytokine Release Syndrome, Tumour Lysis Syndrome
on Jul 16, 2010 Male patient from GERMANY , weighting 207.2 lb, was diagnosed with metastatic gastric cancer and was treated with Herceptin (View Usage). Patient experienced the following unwanted or unexpected effects: cytokine release syndrome, tumour lysis syndrome. Herceptin dosage: Planned 8 Mg/kg, Interrupted After 70 Mg (20 Ml Solution). During the same period patient was treated with TAXOTERE (2 Applications Given) (View Taxotere Review and Taxotere Label ), CISPLATIN (2 Applications Given) (View Cisplatin Review and Cisplatin Label ), FLUOROURACIL (2 Applications Given) (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6882960-2 | Disease Progression
Patient was taking Herceptin (View Usage). Patient had the following side effects: disease progression on Jul 26, 2010 from ECUADOR Additional patient health information: Female patient , 36 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Herceptin dosage: Stop Date: April 2010. Dosing Freq: Each 3 Week. During the same period patient was treated with DOCETAXEL (Stop Date: April 2010. Dosing Freq: Each 3 Week.) (View Docetaxel Review and Docetaxel Label ).